MAP2K7 and lung cancer: In addition to the MEK/ERK signaling pathway, estrogen also activates the PI3K/AKT signaling pathway, another downstream pathway of the EGFR activation, to promote lung cancer cell metastasis through epithelial mesenchymal transition [98].